Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study-Reference-Cited by-同舟云学术

Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study

Published:2023-09-14 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Grymonprez Maxim^ORCID,Steurbaut Stephane,Capiau Andreas,Vauterin Delphine,Van Vaerenbergh Frauke,Mehuys Els,Boussery Koen,De Backer Tine L.,Lahousse Lies^ORCID

Funder

Fonds Wetenschappelijk Onderzoek

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-023-07507-3.pdf

Reference40 articles.

1. Steffel J, Collins R, Antz M et al. 2021 European Heart Rhythm Association practical guide on the Use of Non-Vitamin K antagonist oral anticoagulants in patients with Atrial Fibrillation. Europace: european pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2021;23(10):1612–76.

2. Grymonprez M, Simoens C, Steurbaut S, De Backer TL, Lahousse L. Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. Europace: Eur Pacing Arrhythm Cardiac Electrophysiol : J Working Groups Cardiac Pacing Arrhythm Cardiac Cell Electrophysiol Eur Soc Cardiol. 2022;24(6):887–98.

3. Grymonprez M, De Backer TL, Capiau A, et al. Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study. Br J Clin Pharmacol. 2023;89(4):1360–73.

4. Grymonprez M, Capiau A, Steurbaut S, et al. Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: a belgian nationwide cohort study. Front Cardiovasc Med. 2022;9:994085.

5. Holthuis E, Smits E, Spentzouris G, et al. Increased risk of Stroke due to non-adherence and non-persistence with direct oral anticoagulants (DOACs): real-world analyses using a nested case-control study from the Netherlands, Italy and Germany. Drugs - real world outcomes; 2022.